Roanna Ruiz
Stock Analyst at Leerink Partners
(2.15)
# 3,034
Out of 4,361 analysts
444
Total ratings
45.9%
Success rate
0.4%
Average return
Main Sectors:
Stocks Rated by Roanna Ruiz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VIR Vir Biotechnology | Reiterated: Buy | n/a | $9.03 | - | 33 | May 27, 2026 | |
| CRMD CorMedix | Reiterated: Buy | $13 → $15 | $8.45 | +77.51% | 11 | May 15, 2026 | |
| IBIO iBio, Inc. | Maintained: Buy | $5 → $6 | $1.89 | +217.46% | 3 | May 15, 2026 | |
| AQST Aquestive Therapeutics | Reiterated: Buy | $9 | $4.00 | +125.00% | 24 | May 15, 2026 | |
| UTHR United Therapeutics | Maintained: Buy | $615 | $544.62 | +12.92% | 24 | Mar 2, 2026 | |
| MNKD MannKind | Maintained: Buy | n/a | $3.53 | - | 1 | Feb 25, 2026 | |
| CYTK Cytokinetics | Reiterated: Buy | n/a | $73.68 | - | 30 | Jan 13, 2026 | |
| TRVI Trevi Therapeutics | Reiterated: Buy | $16 | $13.95 | +14.70% | 1 | Nov 18, 2025 | |
| ENTA Enanta Pharmaceuticals | Maintained: Hold | $7 → $9 | $12.67 | -28.97% | 37 | Oct 1, 2025 | |
| HKG: 2137 Brii Biosciences Limited | Reiterated: Hold | $1.00 → $2.00 | $1.11 | +80.18% | 8 | Aug 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 | $1.02 | +586.27% | 6 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $99 | $97.13 | +1.93% | 53 | Aug 22, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $9 | $6.07 | +48.27% | 35 | Aug 20, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $28 | $9.43 | +196.92% | 27 | Aug 14, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $1 | $2.07 | -51.69% | 17 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $107 → $44 | $31.79 | +38.41% | 27 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 → $11 | $5.73 | +91.97% | 11 | Aug 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $10 | $14.36 | -30.36% | 30 | Jul 31, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $135.98 | n/a | 2 | Mar 6, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $5 → $4 | $4.38 | n/a | 23 | May 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 | $5.35 | n/a | 22 | May 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $23 | $70.44 | n/a | 6 | Jan 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $80 | $0.000001 | n/a | 13 | Dec 20, 2022 |
Vir Biotechnology
May 27, 2026
Reiterated: Buy
Price Target: n/a
Current: $9.03
Upside: -
CorMedix
May 15, 2026
Reiterated: Buy
Price Target: $13 → $15
Current: $8.45
Upside: +77.51%
iBio, Inc.
May 15, 2026
Maintained: Buy
Price Target: $5 → $6
Current: $1.89
Upside: +217.46%
Aquestive Therapeutics
May 15, 2026
Reiterated: Buy
Price Target: $9
Current: $4.00
Upside: +125.00%
United Therapeutics
Mar 2, 2026
Maintained: Buy
Price Target: $615
Current: $544.62
Upside: +12.92%
MannKind
Feb 25, 2026
Maintained: Buy
Price Target: n/a
Current: $3.53
Upside: -
Cytokinetics
Jan 13, 2026
Reiterated: Buy
Price Target: n/a
Current: $73.68
Upside: -
Trevi Therapeutics
Nov 18, 2025
Reiterated: Buy
Price Target: $16
Current: $13.95
Upside: +14.70%
Enanta Pharmaceuticals
Oct 1, 2025
Maintained: Hold
Price Target: $7 → $9
Current: $12.67
Upside: -28.97%
Brii Biosciences Limited
Aug 25, 2025
Reiterated: Hold
Price Target: $1.00 → $2.00
Current: $1.11
Upside: +80.18%
Aug 22, 2025
Reiterated: Buy
Price Target: $7
Current: $1.02
Upside: +586.27%
Aug 22, 2025
Maintained: Buy
Price Target: $99
Current: $97.13
Upside: +1.93%
Aug 20, 2025
Reiterated: Buy
Price Target: $9
Current: $6.07
Upside: +48.27%
Aug 14, 2025
Reiterated: Buy
Price Target: $28
Current: $9.43
Upside: +196.92%
Aug 7, 2025
Reiterated: Hold
Price Target: $1
Current: $2.07
Upside: -51.69%
Aug 7, 2025
Reiterated: Buy
Price Target: $107 → $44
Current: $31.79
Upside: +38.41%
Aug 5, 2025
Reiterated: Buy
Price Target: $10 → $11
Current: $5.73
Upside: +91.97%
Jul 31, 2025
Reiterated: Hold
Price Target: $10
Current: $14.36
Upside: -30.36%
Mar 6, 2025
Maintained: Buy
Price Target: n/a
Current: $135.98
Upside: n/a
May 14, 2024
Maintained: Hold
Price Target: $5 → $4
Current: $4.38
Upside: n/a
May 7, 2024
Maintained: Hold
Price Target: $25
Current: $5.35
Upside: n/a
Jan 22, 2024
Maintained: Hold
Price Target: $23
Current: $70.44
Upside: n/a
Dec 20, 2022
Reiterated: Hold
Price Target: $80
Current: $0.000001
Upside: n/a